Samuel S. Lee

机构：University of Calgary · ORCID：0000-0003-4431-272X

发表论文 325 篇 · 总被引 15531 次 · h-index 59

代表论文

• Lipid nanoparticle delivery of TALEN mRNA targeting LPA causes gene disruption and plasma lipoprotein(a) reduction in transgenic mice (2024 · Molecular Therapy · 被引 12)
• Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities (2024 · International Journal of Molecular Sciences · 被引 11)
• Bioprinting of hepatic tissue model using photocrosslinkable dECM-containing composite hydrogel (2025 · Materials Today Bio · 被引 9)
• Lubiprostone Reduces Fat Content on MRI ‐ PDFF in Patients With MASLD : A 48‐Week Randomised Controlled Trial (2025 · Alimentary Pharmacology & Therapeutics · 被引 6)
• Prevalence of cirrhotic cardiomyopathy in liver transplant candidates: Impact on pre- and post-transplant mortality (2025 · Annals of Hepatology · 被引 5)
• Apoptosis in Cardiac Conditions Including Cirrhotic Cardiomyopathy (2025 · International Journal of Molecular Sciences · 被引 5)